Primary Record
ME-344
- In stock
- 1,508 g
- Purity
- 99.4 %
- CAS
- 1374524-68-1
Compound Identifiers & Properties
- CAS
- 1374524-68-1
- PubChem CID
- 68026984
- SMILES
- CC1=C(C=CC2=C1OC[C@H]([C@H]2C3=CC=C(C=C3)O)C4=CC=C(C=C4)O)O
- Canonical SMILES
- Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
Names & Synonyms
- ME-344
- RefChem:156173
- D03IXK
- UNII-843G0TDV51
- 843G0TDV51
- Me 344
- DTXSID701031261
- GTPL7961
- CHEMBL5314386
- ME 344 [WHO-DD]
- SCHEMBL10073998
- SCHEMBL29370582
- DTXCID001516270
- GLXC-15476
- ME344
- MTOR inhibitor (cancer), Novogen
- EX-A10215
- mTOR1/2 Kinase Inhibitor ME-344
- NV-128
- NV-344
- 1374524-68-1
- DB13062
- 4,4'-(7-Hydroxy-8-methylchroman-3,4-diyl)diphenol
- CID:68026984
- SID:483555730
- HY-112749
- MTOR inhibitors (cancer), Marshall Edwards
- CS-0063310
- NS00073416
- J3.728.789J
- (3R,4S)-3,4-bis(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol
- 4,4'-((3R,4S)-7-Hydroxy-8-methylchroman-3,4-diyl)diphenol
- 2H-1-Benzopyran-7-ol, 3,4-dihydro-3,4-bis(4-hydroxyphenyl)-8-methyl-, (3R,4S)-
- Q27083823
- C000597890
- (3R,4S)-3,4-bis(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2H-1-benzopyran-7-ol
- 1374524-55-6